Author: apopescu@pmlive.com

Pharma and the modern patient: creating a real connection

Eliran Malki, co-founder and CEO of Belong.Life, explores what pharma can do to engage the modern patient

Decentralised and hybrid trials – the patient’s voice

ICON’s Gretchen Goller on getting the patient perspective on clinical trial participation

Patient-centricity in rare diseases

Keeping the needs of patients as a guiding principle has been key to Kyowa Kirin’s recent success, says Richard Johnson

Changing Landscape of Clinical Trials Data Capture and Reporting during Covid 19 Pandemic

On January 30, 2020, the WHO declared the novel acute respiratory infection caused by the “SARS-CoV-2” virus, termed “Coronavirus Disease-2019 (COVID-19)” as a Public Health Emergency of International Concern.{9} As of July 20, 2020, over 14 million people worldwide are confirmed to be infected, leading to increasing fatality rates.{10}